AwesomeCapital
Search This Blog
Thursday, February 13, 2020
West Pharmaceutical EPS beats by $0.10, beats on revenue
West Pharmaceutical (NYSE:
WST
): Q4 Non-GAAP EPS of $0.82
beats by $0.10
; GAAP EPS of $0.84
beats by $0.14
.
Revenue of $470.6M (+11.4% Y/Y)
beats by $19.07M
.
Press Release
https://wordpress.com/post/awesomecapital.wordpress.com/110041
Alkermes EPS beats by $0.17, beats on revenue
Alkermes (NASDAQ:
ALKS
): Q4 Non-GAAP EPS of $0.83
beats by $0.17
; GAAP EPS of -$0.03
misses by $0.37
.
Revenue of $412.73M (+30.7% Y/Y)
beats by $8.28M
.
Press Release
https://seekingalpha.com/news/3541604-alkermes-eps-beats-0_17-beats-on-revenue
Agios Pharmaceuticals EPS beats by $0.08, beats on revenue
Agios Pharmaceuticals (NASDAQ:
AGIO
): Q4 GAAP EPS of -$1.60
beats by $0.08
.
Revenue of $35.44M (+18.1% Y/Y)
beats by $1.72M
.
Press Release
https://seekingalpha.com/news/3541609-agios-pharmaceuticals-eps-beats-0_08-beats-on-revenue
Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue
Ironwood Pharmaceuticals (NASDAQ:
IRWD
): Q4 Non-GAAP EPS of $0.30
beats by $0.07
; GAAP EPS of $0.30
beats by $0.08
.
Revenue of $126.3M (-3.4% Y/Y)
beats by $14.24M
.
Press Release
https://seekingalpha.com/news/3541622-ironwood-pharmaceuticals-eps-beats-0_07-beats-on-revenue
Karyopharm Therapeutics EPS misses by $0.08, beats on revenue
Karyopharm Therapeutics (NASDAQ:
KPTI
): Q4 GAAP EPS of -$0.76
misses by $0.08
.
Revenue of $18.1M (+8950.0% Y/Y)
beats by $1.83M
.
Press Release
https://seekingalpha.com/news/3541610-karyopharm-therapeutics-eps-misses-0_08-beats-on-revenue
Laboratory Corporation of America EPS beats by $0.06, beats on revenue
Laboratory Corporation of America (NYSE:
LH
): Q4 Non-GAAP EPS of $2.86
beats by $0.06
; GAAP EPS of $2.32
beats by $0.07
.
Revenue of $2.95B (+5.7% Y/Y)
beats by $30M
.
Press Release
https://seekingalpha.com/news/3541614-laboratory-corporation-of-america-eps-beats-0_06-beats-on-revenue
Blueprint Medicines EPS beats by $0.41, beats on revenue
Blueprint Medicines (NASDAQ:
BPMC
): Q4 GAAP EPS of -$1.35
beats by $0.41
.
Revenue of $51.53M (+4902.9% Y/Y)
beats by $25.53M
.
Press Release
https://seekingalpha.com/news/3541618-blueprint-medicines-and-nbsp-eps-beats-0_41-beats-on-revenue
Newer Posts
Older Posts
Home
Subscribe to:
Comments (Atom)